Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MITO

Stealth BioTherapeutics (MITO) Stock Price, News & Analysis

Stealth BioTherapeutics logo

About Stealth BioTherapeutics Stock (NASDAQ:MITO)

Advanced Chart

Key Stats

Today's Range
$0.32
$0.32
50-Day Range
$0.31
$0.32
52-Week Range
$0.16
$1.03
Volume
N/A
Average Volume
946,105 shs
Market Capitalization
$23.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MITO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stealth BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

MITO Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
See More Headlines

MITO Stock Analysis - Frequently Asked Questions

Stealth BioTherapeutics Corp (NASDAQ:MITO) issued its quarterly earnings results on Thursday, August, 5th. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01.

Stealth BioTherapeutics (MITO) raised $81 million in an initial public offering (IPO) on Friday, February 15th 2019. The company issued 6,200,000 shares at $12.00-$14.00 per share. Jefferies, Evercore ISI and BMO Capital Markets acted as the underwriters for the IPO and Nomura was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stealth BioTherapeutics investors own include Tesla (TSLA), TherapeuticsMD (TXMD), NIO (NIO), Plug Power (PLUG), Allena Pharmaceuticals (ALNA), SCYNEXIS (SCYX) and Tonix Pharmaceuticals (TNXP).

Company Calendar

Last Earnings
8/05/2021
Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MITO
CIK
1696396
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.52)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$52.53 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-142.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.68
Quick Ratio
3.68

Sales & Book Value

Annual Sales
$21.09 million
Price / Sales
1.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.79) per share
Price / Book
-0.41

Miscellaneous

Outstanding Shares
73,552,000
Free Float
N/A
Market Cap
$23.54 million
Optionable
Not Optionable
Beta
1.46
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:MITO) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners